Evidence map›Paper›PMID 41629437›Full record

ArticleJournal of clinical immunology2026

Follicular Helper T Cells and B Cell Maturation in Patients with 22q11.2 Deletion Syndrome and Recurrent Infections.

Nouf Alsaati, Katherine Beigel, Kelly Maurer, Sarah E Henrickson, Montana Knight, Audrey Green, Victoria Giunta, Daniel E McGinn, Bekah Wang, T Blaine Crowley and 2 more

Abstract read
In one paragraph

Article in Journal of clinical immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Nouf AlsaatiDivision of Allergy and Immunology, Children's Hospital of Philadelphia, Philadelphia, PA, 19104, USA.
Katherine BeigelDepartment of Biomedical and Health Informatics, Children's Hospital of Philadelphia, Philadelphia, PA, 19104, USA.
Kelly MaurerDivision of Allergy and Immunology, Children's Hospital of Philadelphia, Philadelphia, PA, 19104, USA.
Sarah E HenricksonDivision of Allergy and Immunology, Children's Hospital of Philadelphia, Philadelphia, PA, 19104, USA.
Montana KnightDivision of Allergy and Immunology, Children's Hospital of Philadelphia, Philadelphia, PA, 19104, USA.
Audrey GreenDivision of Human Genetics, Children's Hospital of Philadelphia, Philadelphia, PA, 19104, USA.
Victoria GiuntaDivision of Human Genetics, Children's Hospital of Philadelphia, Philadelphia, PA, 19104, USA.
Daniel E McGinnDivision of Human Genetics, Children's Hospital of Philadelphia, Philadelphia, PA, 19104, USA.
Bekah WangDivision of Human Genetics, Children's Hospital of Philadelphia, Philadelphia, PA, 19104, USA.
T Blaine CrowleyDivision of Human Genetics, Children's Hospital of Philadelphia, Philadelphia, PA, 19104, USA.
Donna M McDonald-McGinnDivision of Human Genetics, Children's Hospital of Philadelphia, Philadelphia, PA, 19104, USA.
Kathleen E SullivanDivision of Allergy and Immunology, Children's Hospital of Philadelphia, Philadelphia, PA, 19104, USA. sullivank@chop.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purpose22q11.2 Deletion Syndrome has been primarily described as a disorder of T cell production secondary to thymic hypoplasia. However, there is great complexity in the clinical picture with infections, autoimmunity, and inflammation occurring. Emerging evidence suggests that qualitative T cell dysfunction occurs, and the goal of this study was to utilize single-cell RNA-seq to better define altered gene expression patterns to inform on the mechanisms associated with recurrent infections.

methodsWe utilized single-cell RNA-seq to define distinct populations in 22q11.2 Deletion Syndrome (N = 13) and controls (N = 11) as well as within a subcohort of patients with 22q11.2 Deletion Syndrome and recurrent infections.

resultsWhen we analyzed differentially expressed genes, we identified a signature of type I interferons across all cell types. Within the T cell compartment, and particularly within the follicular helper T cells, we identified a senescence signature. The alterations found in T cells were most substantial in the patients with recurrent infection.

conclusionsWhile T cell numbers can often normalize in patients with 22q11.2 Deletion Syndrome, our data indicate significantly altered function as defined by differentially expressed genes and aligned with what is known about T cell senescence. The effect was greatest in the patients with recurrent infection. This would be expected to impact T cell function and may account for ongoing symptoms, reduced B cell maturation, and possibly the risk of immune dysregulation.

Indexed as

B-LymphocytesDiGeorge SyndromeInfectionsT Follicular Helper CellsAdolescentCell DifferentiationChildChild, PreschoolFemaleGene Expression ProfilingHumansMaleRecurrence22q11.2 deletion syndromeAtypical b cellsDiGeorge syndromeFollicular helper t cellT cell senescence

Identifiers

PMID41629437
PMCPMC12913360

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.